Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Expression Analysis of a Panel of Cancer-Testis Antigens in Bladder Cancer Publisher Pubmed



Yazarlou F1 ; Kholghioskooei V2 ; Afsharpad M3 ; Nekoohesh L4 ; Moharrami T5 ; Rad HM6 ; Ghafourifard S2, 7 ; Modarressi MH1, 3
Authors

Source: Personalized Medicine Published:2018


Abstract

Aim: Cancer-testis antigens (CTAs) have specific expression in gametogenic tissues and aberrant expression in cancers. Materials & methods: We assessed expression of five testis-specific genes namely KIF2B, CST8, TMEM225, RBM46, OAZ3 in bladder cancer tissues, adjacent non-neoplastic tissues and urinary cell pellets (UCPs) of bladder cancer patients compared with nonmalignant conditions.Results: Expressions of all CTAs were higher in UCPs of bladder cancer patients compared with nonmalignant conditions. RBM46 expression in UCPs was higher in patients with recurrent tumors compared with primary tumors and in patients without hematuria compared with those having hematuria. TMEM225 expression in tumoral tissues was higher in high-grade tumors compared with low-grade tumors. Conclusion: Expression analysis of CTAs in UCP might provide diagnostic information about bladder cancer. © 2018 Future Medicine Ltd.
Related Docs
View other Related Docs
1. Expression Analysis of Apoptosis-Related Genes in Bladder Cancer Patients, Meta Gene (2018)
2. Cancer-Testis Antigens As New Candidate Diagnostic Biomarkers for Transitional Cell Carcinoma of Bladder, Pathology and Oncology Research (2019)
3. Urine Exosome Gene Expression of Cancer-Testis Antigens for Prediction of Bladder Carcinoma, Cancer Management and Research (2018)
Experts (# of related papers)
View all Related Experts
Mohammad Hossein Modarressi (6)
Mohammad Reza Nowroozi (4)
Other Related Docs
4. An Introduction to Expression and Regulation of Testicular Cancer Antigens: Review Article, Tehran University Medical Journal (2018)
5. Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers, Immunological Investigations (2016)
6. Exploring a Desirable Quadr-Mrnas Panel for Non-Invasive and Ultrasensitive Bladder Cancer Diagnosis: In-Silico and Clinical Studies, Current Medicinal Chemistry (2025)
7. Evaluation of Htert, Krt7, and Survivin in Urine for Noninvasive Detection of Bladder Cancer Using Real‐Time Pcr, BMC Urology (2021)
8. Evaluation of Igf2, Krt14, and Krt20 As Urinary Biomarkers in Patients With Bladder Cancer, Reports of Biochemistry and Molecular Biology (2023)
9. Molecular Biology, Genetic, and Epigenetics of Bladder Tumor, (2024)
10. The Value of Epidermal Growth Factor Receptor Expression in Predicting Aggressive Behaviors of Bladder Neoplasms, Nephro-Urology Monthly (2023)
11. The Incidence and Prognostic Role of Β-Catenin and E-Cadherin Biomarkers in Bladder Neoplasms, a Cross-Sectional Study, International Journal of Surgery Open (2023)
12. Investigation of New Autoantibodies in Urothelial Bladder Cancer for Biomarker Discovery Using Immunoproteomics, Discover Oncology (2025)
13. Urinary Tert Promoter Mutations Are Detectable up to 10 Years Prior to Clinical Diagnosis of Bladder Cancer: Evidence From the Golestan Cohort Study, EBioMedicine (2020)
14. Tert Promoter Mutations As Simple and Non-Invasive Urinary Biomarkers for the Detection of Urothelial Bladder Cancer in a High-Risk Region, International Journal of Molecular Sciences (2022)
15. Cancer/Testis Genes in Relation to Sperm Biology and Function, Iranian Journal of Basic Medical Sciences (2017)
16. Molecular Characteristics of Bladder Tumor: Increased Gene Expression of Mage-A6 and Mage-A11 With Decreased Microrna-34A and Microrna-125B, Iranian Journal of Allergy# Asthma and Immunology (2022)
17. Reference Gene Validation for Relative Quantification Analysis of Transcripts in Urinary Exfoliated Cells Among Urothelial Bladder Carcinoma Patients, Meta Gene (2017)
18. Comparative Proteomics Analysis in Different Stages of Urothelial Bladder Cancer for Identification of Potential Biomarkers: Highlighted Role for Antioxidant Activity, Clinical Proteomics (2023)
19. Deletion/Duplication Mutation Screening of Tp53 Gene in Patients With Transitional Cell Carcinoma of Urinary Bladder Using Multiplex Ligation-Dependent Probe Amplification, Cancer Medicine (2016)
20. Association of Thrombomodulin Expression With Bladder Cancer Grade, Stage, and Recurrence: A Single-Center Prospective Pilot Study, Iranian Journal of Pathology (2025)